Augnito secures undisclosed funding from Dharmendra Ghai to scale medical voice AI
What's the deal? AugnitoDealroom has a profile for this one. Try Dealroom →, a Dubai-based medical speech AI company, has secured an investment from Dharmendra GhaiDealroom has a profile for this one. Try Dealroom →. The deal's value was not disclosed. The company plans to use the funds to accelerate development and deployment of its healthcare technology globally.
Led by chief executive officer Rustom LawyerDealroom has a profile for this one. Try Dealroom →, Augnito combines natural language processing, generative AI, and multilingual speech recognition to streamline clinical documentation. It serves more than 375 hospitals across over 25 countries.
A key differentiator: native Arabic language and accent support, a feature that gives it an edge in the Middle East market.
Why now? Augnito has been building momentum in the region. It recently signed partnerships with several major Middle Eastern healthcare facilities, including King's College Hospital London (Dubai), Prime Healthcare, Dallah Hospitals, King Abdulaziz University Hospital, and RAK Hospital.
The investment comes as demand for AI-driven clinical tools grows worldwide, with hospitals under pressure to cut administrative burdens and free up doctors' time for patient care.
What could go wrong? The undisclosed funding amount raises questions about the scale of this raise. Without knowing the figure, it is hard to assess whether Augnito has the capital to compete globally against well-funded rivals in the medical AI space.
Healthcare AI also faces regulatory scrutiny and data privacy concerns — particularly when operating across 25-plus countries with varying compliance standards.
The signal: Augnito is classified as a "breakout" company on Dealroom, suggesting meaningful commercial traction behind its 375-hospital footprint. Dharmendra GhaiDealroom has a profile for this one. Try Dealroom →, operating as an investment fund rather than a typical angel, points to a more structured bet on clinical voice AI — a niche where multilingual accuracy remains a genuine barrier to entry, particularly for Arabic-language healthcare markets.
Read more: startuprise.org
